-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Upgrades Dr Reddy's Laboratories to Buy, Raises Price Target to $16.9

Benzinga·06/05/2025 12:07:15
Listen to the news
HSBC analyst Damayanti Kerai upgrades Dr Reddy's Laboratories (NYSE:RDY) from Hold to Buy and raises the price target from $14.44 to $16.9.